Genetic signature predicts diabetes diagnosis

April 9, 2018, University of Queensland
Genetic signature predicts diabetes diagnosis
Credit: University of Queensland

University of Queensland researchers have found a way to identify infants who will go on to develop type 1 diabetes.

UQ Diamantina Institute researcher Professor Ranjeny Thomas said the discovery would lead to the development of better screening tests to identify at highest risk.

"Most children diagnosed with type 1 do not have a family history, hence population screening could reduce life threatening complications before diagnosis," Professor Thomas said.

"By looking at a child's gene activation pattern early in life, we are able to identify those who will progress to develop .

"Once they have two antibodies, it's highly likely they will go on to develop type 1 diabetes.

"As antibodies are infrequent in the general population, we are currently only using them to screen children from high-risk families in research programs."

The team examined data collected over 10 years from two cohorts of children at risk of type 1 diabetes.

They identified a seven-gene expression signature in infants in the first year of life, which when combined with a genetic risk score, identified children with a high-risk of developing diabetes antibodies.

"This signature can screen out infants who are at low risk of developing type 1 diabetes, so that monitoring can be focused on children with highest risk," Professor Thomas said.

Lady Cilento Children's Hospital paediatric endocrinologist Dr. Mark Harris said monitoring an at-risk child reduced the likelihood they would present with diabetic ketoacidosis, a medical emergency.

"In children who are part of a monitoring program, the incidence of diabetic ketoacidosis is less than five per cent," he said.

"Currently we're seeing up to 40 per cent of children presenting with .

"Through population screening we'd be able to reduce that dramatically, while trialling preventive strategies."

Type 1 diabetes occurs when a person's immune system attacks insulin-producing cells in the pancreas, and is most commonly diagnosed in children.

There is no cure, and patients require daily insulin to control blood sugar levels.

The research is published in JCI Insight.

Explore further: Kids with regular health care less likely to have life-threatening diabetic ketoacidosis

More information: Ahmed M. Mehdi et al. A peripheral blood transcriptomic signature predicts autoantibody development in infants at risk of type 1 diabetes, JCI Insight (2018). DOI: 10.1172/jci.insight.98212

Related Stories

Kids with regular health care less likely to have life-threatening diabetic ketoacidosis

April 9, 2018
A key factor in reducing the risk of diabetic ketoacidosis (DKA), a potentially life-threatening complication of type 1 diabetes, in children at diagnosis of type 1 diabetes, is having a regular health care provider, according ...

Genes can help predict children's risk of type 1 diabetes

April 3, 2018
A type 1 diabetes genetic score can identify infants at risk for pre-symptomatic type 1 diabetes and could be used to enroll children into type 1 diabetes prevention trials, according to a study published this week in PLOS ...

Insulin pumps associated with lower risk of serious complications among young patients with type 1 diabetes

October 10, 2017
Compared with insulin injections, insulin pump therapy among young patients with type 1 diabetes was associated with a lower risk of diabetic ketoacidosis and severe hypoglycemia, according to a study published by JAMA.

Modifying baby formula doesn't prevent type 1 diabetes in children

January 2, 2018
The long-awaited results from the first large international trial to try to prevent type 1 diabetes shows that modified baby formula in which cow's milk proteins have been split does not prevent type 1 diabetes in children ...

Researchers find biomarker that could help predict the onset of type 1 diabetes

March 28, 2017
A significant finding has been made by the 3U Diabetes Consortium, of Dublin City University, Maynooth University and the Royal College of Surgeons in Ireland (RCSI), which has the potential to contribute to the identification ...

Variation in genetic risk explains which people develop type 1 diabetes in later life

September 12, 2017
Having certain genetic variants could explain why people can develop type 1 diabetes at markedly different ages, including later in life, says new University of Exeter research being presented at this year's annual meeting ...

Recommended for you

Bariatric surgery successes lead to type 2 diabetes treatment

April 24, 2018
Bariatric surgery has long yielded almost immediate health benefits for patients with type 2 diabetes, and new findings on the reasons for remission may be the key to developing drug alternatives to surgery.

Hacking human 'drug trafficking' network could make diabetes treatments more effective

April 23, 2018
Making tiny changes to existing diabetes treatments can alter how they interact with cells, and potentially make the medicines more effective.

Vitamin D deficiency linked to greater risk of diabetes

April 19, 2018
An epidemiological study conducted by researchers at University of California San Diego School of Medicine and Seoul National University suggests that persons deficient in vitamin D may be at much greater risk of developing ...

One class of drug used to treat type 2 diabetes may not reduce the risk of death when compared with placebo

April 17, 2018
One class of drug used to treat type 2 diabetes may not reduce the risk of death when compared with placebo, suggests new findings.

People with Type 2 diabetes who eat breakfast later, more likely to have a higher BMI

April 16, 2018
Being an "evening person" is linked to higher body mass indices among people with Type 2 diabetes, and having breakfast later in the day seems to be what drives this association, according to a new paper in the journal Diabetic ...

Continuous glucose monitors proven cost-effective, add to quality of life for diabetics

April 12, 2018
Continuous glucose monitors (CGM) offer significant, daily benefits to people with type 1 diabetes, providing near-real time measurements of blood sugar levels, but they can be expensive. A new study by researchers from the ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.